Processing .....please wait.. 
The article has been forwarded.... 
Ranbaxy sets out to conquer global markets
By siliconindia
|
Wednesday, 22 October 2003, 19:30 IST
KOLKATA: To leverage its strength in the global antibiotic markets, Indian pharmaceutical giant, Ranbaxy Laboratory Limited is now betting big on the revolutionary OD (once-a-day dosage) antibiotic formulations.
The company is planning to go global with this niche segment and has lined up a strategy for phased launch of these formulations and future growth.
The formulations that are being considered for launch by Ranbaxy in different markets across the world are its three blockbuster OD formulations in the domestic market --- ciprofloxacin OD (Cifran OD), ofloxacin OD (Zanocin OD) and clarithromycin OD (Crixan OD).
For starters, Ranbaxy has planned launch of the OD antibiotic formulations under its own brand in markets where it already has strong presence like China, Brazil, Myanmar, and Cambodia.